FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Hans Brunner

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Double-Blind Method

Co-author Network

Publications

TOP 3
Christopher Hasler; Jürg Nussberger; Marc Maillard; Andrei Forclaz; Hans R Brunner; Michel Burnier
Sustained 24-hour blockade of the renin-angiotensin system: a high dose of a long-acting blocker is as effective as a lower dose combined with an angiotensin-converting enzyme inhibitor.
Ana P Silva; Jocelyne E Kaufmann; Cécile Vivancos; Stanislav Fakan; Cláudia Cavadas; Phillip Shaw; Hans R Brunner; Ulrich Vischer; Eric Grouzmann
Neuropeptide Y expression, localization and cellular transducing effects in HUVEC.
Noureddine Brakch; Saad Abdel-Sayed; Flore Allemandou; Qing Wang; Jean-François Aubert; Hans R Brunner; Jürg Nussberger
Renal endothelin receptor type B upregulation in rats with low or high renin hypertension.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Hans Brunner (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2005: Christopher Hasler; Jürg Nussberger; Marc Maillard; Andrei Forclaz; Hans R Brunner; Michel Burnier
Sustained 24-hour blockade of the renin-angiotensin system: a high dose of a long-acting blocker is as effective as a lower dose combined with an angiotensin-converting enzyme inhibitor.
Clinical pharmacology and therapeutics 2005;78(5):501-7.
2005: Ana P Silva; Jocelyne E Kaufmann; Cécile Vivancos; Stanislav Fakan; Cláudia Cavadas; Phillip Shaw; Hans R Brunner; Ulrich Vischer; Eric Grouzmann
Neuropeptide Y expression, localization and cellular transducing effects in HUVEC.
Biology of the cell / under the auspices of the European Cell Biology Organization 2005;97(6):457-67.
2004: Noureddine Brakch; Saad Abdel-Sayed; Flore Allemandou; Qing Wang; Jean-François Aubert; Hans R Brunner; Jürg Nussberger
Renal endothelin receptor type B upregulation in rats with low or high renin hypertension.
Journal of hypertension 2004;22(9):1797-803.
2004: Lucia Mazzolai; Michel A Duchosal; Martine Korber; Karima Bouzourene; Jean-François Aubert; Hiroyuki Hao; Véronique Vallet; Hans R Brunner; Jürg Nussberger; Giulio Gabbiani; Daniel Hayoz
Endogenous angiotensin II induces atherosclerotic plaque vulnerability and elicits a Th1 response in ApoE-/- mice.
Hypertension 2004;44(3):277-82.
2004: Anne Zanchi; Arnaud Chiolero; Marc Maillard; Jürg Nussberger; Hans R Brunner; Michel Burnier
Effects of the peroxisomal proliferator-activated receptor-gamma agonist pioglitazone on renal and hormonal responses to salt in healthy men.
The Journal of clinical endocrinology and metabolism 2004;89(3):1140-5.
2004: Qing Wang; Hans R Brunner; Michel Burnier
Determination of cardiac contractility in awake unsedated mice with a fluid-filled catheter.
American journal of physiology. Heart and circulatory physiology 2004;286(2):H806-14.
2004: Hans R Brunner
Clinical efficacy and tolerability of olmesartan.
Clinical therapeutics 2004;26 Suppl A():A28-32.
2004: Grégoire Wuerzner; Arnaud Chioléro; Marc Maillard; Jürg Nussberger; Hans R Brunner; Michel Burnier; Arnaud Chiclero
Angiotensin II receptor blockade prevents acute renal sodium retention induced by low levels of orthostatic stress.
Kidney international 2004;65(1):238-44.
2003: Saad Abdel-Sayed; Hans R Brunner; Jürg Nussberger
Volume expansion enhances plasma endothelin-1.
American journal of hypertension 2003;16(12):1057-61.
2003: Ana P Silva; Cláudia Cavadas; Bénédicte Baïsse-Agushi; Olivier Spertini; Hans R Brunner; Eric Grouzmann
NPY, NPY receptors, and DPP IV activity are modulated by LPS, TNF-alpha and IFN-gamma in HUVEC.
Regulatory peptides 2003;116(1-3):71-9.
2003: Eric Grouzmann; Cláudia Cavadas; Daniela Grand; Martine Moratel; Jean-François Aubert; Hans R Brunner; Lucia Mazzolai
Blood sampling methodology is crucial for precise measurement of plasma catecholamines concentrations in mice.
Pflügers Archiv : European journal of physiology 2003;447(2):254-8.
2003: Saad Abdel-Sayed; Jürg Nussberger; Jean-François Aubert; Peter Gohlke; Hans R Brunner; Noureddine Brakch
Measurement of plasma endothelin-1 in experimental hypertension and in healthy subjects.
American journal of hypertension 2003;16(7):515-21.
2003: Hans R Brunner; Petra Laeis
Clinical efficacy of olmesartan medoxomil.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 2003;21(2):S43-6.
2003: Michel Burnier; Valérie Santschi; Bernard Favrat; Hans R Brunner
Monitoring compliance in resistant hypertension: an important step in patient management.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 2003;21(2):S37-42.
2003: Cláudia Cavadas; Daniela Grand; François Mosimann; Maria Dulce Cotrim; Carlos Alberto Fontes Ribeiro; Hans R Brunner; Eric Grouzmann
Angiotensin II mediates catecholamine and neuropeptide Y secretion in human adrenal chromaffin cells through the AT1 receptor.
Regulatory peptides 2003;111(1-3):61-5.
2003: Hans R Brunner; Klaus O Stumpe; Andrzej Januszewicz
Antihypertensive efficacy of olmesartan medoxomil and candesartan cilexetil assessed by 24-hour ambulatory blood pressure monitoring in patients with essential hypertension.
Clinical drug investigation 2003;23(7):419-30.
2003: Andrei Forclaz; Marc Maillard; Jürg Nussberger; Hans R Brunner; Michel Burnier
Angiotensin II receptor blockade: is there truly a benefit of adding an ACE inhibitor?
Hypertension 2003;41(1):31-6.
2003: Mélanie Mattart; Lucia Mazzolai; Céline Chambaz; Daniel Hayoz; Hans R Brunner; Paolo Silacci
ET-1 and NOS III gene expression regulation by plaque-free and plaque-prone hemodynamic conditions.
Biorheology 2003;40(1-3):289-97.
2002: Cláudia Cavadas; Ana P Silva; Maria Dulce Cotrim; C A Fontes Ribeiro; Hans R Brunner; Eric Grouzmann
Differential secretion of catecholamine and neuropeptide Y in response to KCl from mice chromaffin cells.
Annals of the New York Academy of Sciences 2002;971():335-7.
2002: Cláudia Cavadas; C A Fontes Ribeiro; Maria Dulce Cotrim; François Mosimann; Hans R Brunner; Eric Grouzmann
Catecholamine and neuropeptide Y secretion from human adrenal chromaffin cells: effect of nicotine and KCl.
Annals of the New York Academy of Sciences 2002;971():332-4.
2002: Frédéric Regamey; Marc Maillard; Jürg Nussberger; Hans R Brunner; Michel Burnier
Renal hemodynamic and natriuretic effects of concomitant Angiotensin-converting enzyme and neutral endopeptidase inhibition in men.
Hypertension 2002;40(3):266-72.
2002: Marc Maillard; Christine Perregaux; Catherine Centeno; Joachim Stangier; Wolfgang Wienen; Hans R Brunner; Michel Burnier
In vitro and in vivo characterization of the activity of telmisartan: an insurmountable angiotensin II receptor antagonist.
The Journal of pharmacology and experimental therapeutics 2002;302(3):1089-95.
2002: Noureddine Brakch; Flore Allemandou; Cláudia Cavadas; Eric Grouzmann; Hans R Brunner
Dibasic cleavage site is required for sorting to the regulated secretory pathway for both pro- and neuropeptide Y.
Journal of neurochemistry 2002;81(6):1166-75.
2002: Qing Wang; Edith Hummler; Jürg Nussberger; Sophie Clément; Giulio Gabbiani; Hans R Brunner; Michel Burnier
Blood pressure, cardiac, and renal responses to salt and deoxycorticosterone acetate in mice: role of Renin genes.
Journal of the American Society of Nephrology : JASN 2002;13(6):1509-16.
2002: François P Pralong; Christine Gonzales; Marie-Jeanne Voirol; Richard D Palmiter; Hans R Brunner; Rolf C Gaillard; Josiane Seydoux; Thierry Pedrazzini
The neuropeptide Y Y1 receptor regulates leptin-mediated control of energy homeostasis and reproductive functions.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2002;16(7):712-4.
2002: Hans R Brunner
The new oral angiotensin II antagonist olmesartan medoxomil: a concise overview.
Journal of human hypertension 2002;16 Suppl 2():S13-6.
2002: Hans R Brunner; Haralambos Gavras
Angiotensin blockade for hypertension: a promise fulfilled.
Lancet 2002;359(9311):990-2.
2002: Chantal Csajka; Thierry Buclin; Karin Fattinger; Hans R Brunner; Jérôme Biollaz
Population pharmacokinetic-pharmacodynamic modelling of angiotensin receptor blockade in healthy volunteers.
Clinical pharmacokinetics 2002;41(2):137-52.
2002: Marc Maillard; Grégoire Würzner; Jürg Nussberger; Catherine Centeno; Michel Burnier; Hans R Brunner
Comparative angiotensin II receptor blockade in healthy volunteers: the importance of dosing.
Clinical pharmacology and therapeutics 2002;71(1):68-76.
2002: Jürg Nussberger; Grégoire Wuerzner; Chris Jensen; Hans R Brunner
Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril.
Hypertension 2002;39(1):E1-8.
2001: Corinne Pellieux; Alessandro Foletti; G Peduto; Jean-François Aubert; Jürg Nussberger; Friedrich Beermann; Hans R Brunner; Thierry Pedrazzini
Dilated cardiomyopathy and impaired cardiac hypertrophic response to angiotensin II in mice lacking FGF-2.
The Journal of clinical investigation 2001;108(12):1843-51.
2001: Cláudia Cavadas; Ana P Silva; François Mosimann; Maria Dulce Cotrim; C A Fontes Ribeiro; Hans R Brunner; Eric Grouzmann
NPY regulates catecholamine secretion from human adrenal chromaffin cells.
The Journal of clinical endocrinology and metabolism 2001;86(12):5956-63.
2001: Grégoire Würzner; J C Gerster; Arnaud Chiolero; Marc Maillard; Claire-Lise Fallab-Stubi; Hans R Brunner; Michel Burnier
Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia and gout.
Journal of hypertension 2001;19(10):1855-60.
2001: Grégoire Würzner; Arnaud Chiolero; Marc Maillard; Jürg Nussberger; D Hayoz; Hans R Brunner; Michel Burnier
Renal and neurohormonal responses to increasing levels of lower body negative pressure in men.
Kidney international 2001;60(4):1469-76.
2001: D Sieg-Dobrescu; Michel Burnier; Daniel Hayoz; Hans R Brunner; Bernard Waeber
The return of increased blood pressure after discontinuation of antihypertensive treatment is associated with an impaired post-ischemic skin blood flow response.
Journal of hypertension 2001;19(8):1387-92.
2001: Hans R Brunner; Jürg Nussberger
Relevance of clinical pharmacological models for the evaluation of therapeutic dose range of an AT1-receptor antagonist.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 2001;19(1):S15-20.
2001: Qing Wang; Edith Hummler; Marc Maillard; Jürg Nussberger; Bernard C Rossier; Hans R Brunner; Michel Burnier
Compensatory up-regulation of angiotensin II subtype 1 receptors in alpha ENaC knockout heterozygous mice.
Kidney international 2001;59(6):2216-21.
2001: Michel Burnier; M P Schneider; Arnaud Chioléro; C L Stubi; Hans R Brunner
Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions.
Journal of hypertension 2001;19(2):335-41.
2000: Anastasia Murat; Corinne Pellieux; Hans R Brunner; Thierry Pedrazzini
Calcineurin blockade prevents cardiac mitogen-activated protein kinase activation and hypertrophy in renovascular hypertension.
The Journal of biological chemistry 2000;275(52):40867-73.
2000: Michel Burnier; M L Monod; Arnaud Chioléro; Marc Maillard; Jürg Nussberger; Hans R Brunner
Renal sodium handling in acute and chronic salt loading/depletion protocols: the confounding influence of acute water loading.
Journal of hypertension 2000;18(11):1657-64.
2000: Marc Maillard; J Rossat; Hans R Brunner; Michel Burnier
Tasosartan, enoltasosartan, and angiotensin II receptor blockade: the confounding role of protein binding.
The Journal of pharmacology and experimental therapeutics 2000;295(2):649-54.
2000: Arnaud Chiolero; Marc Maillard; Jürg Nussberger; Hans R Brunner; Michel Burnier
Proximal sodium reabsorption: An independent determinant of blood pressure response to salt.
Hypertension 2000;36(4):631-7.
2000: Daniel Hayoz; G Bizzini; Bernard Noël; Michèle Depairon; Michel Burnier; C Fauveau; A Rouillon; R Brouard; Hans R Brunner
Effect of SR 49059, a V1a vasopressin receptor antagonist, in Raynaud's phenomenon.
Rheumatology (Oxford, England) 2000;39(10):1132-8.
2000: Corinne Pellieux; T Sauthier; Jean-François Aubert; Hans R Brunner; Thierry Pedrazzini
Angiotensin II-induced cardiac hypertrophy is associated with different mitogen-activated protein kinase activation in normotensive and hypertensive mice.
Journal of hypertension 2000;18(9):1307-17.
2000: Lucia Mazzolai; Thierry Pedrazzini; F Nicoud; Giulio Gabbiani; Hans R Brunner; Jürg Nussberger
Increased cardiac angiotensin II levels induce right and left ventricular hypertrophy in normotensive mice.
Hypertension 2000;35(4):985-91.
2000: Marc Maillard; J Rossat; Jürg Nussberger; J Ramis; Caridad Pontes; Michel Burnier; Hans R Brunner
Pharmacologic profile of UR-7247, an orally active angiotensin II AT1 receptor antagonist, in healthy volunteers. p6.
Journal of cardiovascular pharmacology 2000;35(3):383-9.
2000: M Burnier; Hans R Brunner
Angiotensin II receptor antagonists.
Lancet 2000;355(9204):637-45.
2000: Corinne Pellieux; T Sauthier; Andrea Domenighetti; D J Marsh; Richard D Palmiter; Hans R Brunner; Thierry Pedrazzini
Neuropeptide Y (NPY) potentiates phenylephrine-induced mitogen-activated protein kinase activation in primary cardiomyocytes via NPY Y5 receptors.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(4):1595-600.
2000: Paolo Silacci; K Formentin; K Bouzourène; F Daniel; Hans R Brunner; Daniel Hayoz
Unidirectional and oscillatory shear stress differentially modulate NOS III gene expression.
Nitric oxide : biology and chemistry / official journal of the Nitric Oxide Society 2000;4(1):47-56.
2000: Qing Wang; Jean-Daniel Horisberger; Marc Maillard; Hans R Brunner; Bernard C Rossier; Michel Burnier
Salt- and angiotensin II-dependent variations in amiloride-sensitive rectal potential difference in mice.
Clinical and experimental pharmacology & physiology 2000;27(1-2):60-6.
2000: P Rousso; Thierry Buclin; Jürg Nussberger; F Brunner-Ferber; Hans R Brunner; Jérôme Biollaz
Bioavailability of repeated oral administration of MDL 100,240, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase in healthy volunteers.
European journal of clinical pharmacology 2000;55(10):749-54.
1999: Marc Maillard; Lucia Mazzolai; V Daven; Catherine Centeno; Jürg Nussberger; Hans R Brunner; Michel Burnier
Assessment of angiotensin II receptor blockade in humans using a standardized angiotensin II receptor-binding assay.
American journal of hypertension 1999;12(12 Pt 1-2):1201-8.
1999: Michel Burnier; A F Fricker; D Hayoz; Jürg Nussberger; Hans R Brunner
Pharmacokinetic and pharmacodynamic effects of YM087, a combined V1/V2 vasopressin receptor antagonist in normal subjects.
European journal of clinical pharmacology 1999;55(9):633-7.
1999: J Rossat; Marc Maillard; Jürg Nussberger; Hans R Brunner; Michel Burnier
Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects.
Clinical pharmacology and therapeutics 1999;66(1):76-84.
1999: Michel Burnier; Hans R Brunner
Comparative antihypertensive effects of angiotensin II receptor antagonists.
Journal of the American Society of Nephrology : JASN 1999;10 Suppl 12():S278-82.
1999: P Rousso; Thierry Buclin; Jürg Nussberger; Laurent A Décosterd; S D La Roche; F Brunner-Ferber; Hans R Brunner; Jérôme Biollaz
Effects of a dual inhibitor of angiotensin converting enzyme and neutral endopeptidase, MDL 100,240, on endocrine and renal functions in healthy volunteers.
Journal of hypertension 1999;17(3):427-37.
1999: Lucia Mazzolai; Marc Maillard; J Rossat; Jürg Nussberger; Hans R Brunner; Michel Burnier
Angiotensin II receptor blockade in normotensive subjects: A direct comparison of three AT1 receptor antagonists.
Hypertension 1999;33(3):850-5.
1998: A F Fricker; Jürg Nussberger; S Meilenbrock; Hans R Brunner; Michel Burnier
Effect of indomethacin on the renal response to angiotensin II receptor blockade in healthy subjects.
Kidney international 1998;54(6):2089-97.
1998: Michel Burnier; Hans R Brunner
Angiotensin II receptor antagonists in hypertension.
Kidney international. Supplement 1998;68():S107-11.
1998: B Rutschmann; D Evequoz; Jean-François Aubert; Hans R Brunner; Bernard Waeber
Vasopressin dilates the rat carotid artery by stimulating V1 receptors.
Journal of cardiovascular pharmacology 1998;32(4):637-41.
1998: A Pechère-Bertschi; Jürg Nussberger; Jérôme Biollaz; M Fahti; E Grouzmann; T Morgan; Hans R Brunner; Michel Burnier
Circadian variations of renal sodium handling in patients with orthostatic hypotension.
Kidney international 1998;54(4):1276-82.
1998: Anne Zanchi; N Stergiopulos; Hans R Brunner; Daniel Hayoz
Differences in the mechanical properties of the rat carotid artery in vivo, in situ, and in vitro.
Hypertension 1998;32(1):180-5.
1998: Thierry Pedrazzini; Josiane Seydoux; P Künstner; Jean-François Aubert; Eric Grouzmann; Friedrich Beermann; Hans R Brunner
Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor.
Nature medicine 1998;4(6):722-6.
1998: Lucia Mazzolai; Jürg Nussberger; Jean-François Aubert; D B Brunner; Giulio Gabbiani; Hans R Brunner; Thierry Pedrazzini
Blood pressure-independent cardiac hypertrophy induced by locally activated renin-angiotensin system.
Hypertension 1998;31(6):1324-30.
1998: Hans R Brunner
Endothelin inhibition as a biologic target for treating hypertension.
American journal of hypertension 1998;11(4 Pt 3):103S-109S.
1998: A Pechère-Bertschi; Jürg Nussberger; L Decosterd; C Armagnac; J Sissmann; M Bouroudian; Hans R Brunner; Michel Burnier
Renal response to the angiotensin II receptor subtype 1 antagonist irbesartan versus enalapril in hypertensive patients.
Journal of hypertension 1998;16(3):385-93.
1998: P Rousso; Thierry Buclin; Jürg Nussberger; F Brunner-Ferber; Hans R Brunner; Jérôme Biollaz
Effects of MDL 100,240, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase on the vasopressor response to exogenous angiotensin I and angiotensin II challenges in healthy volunteers.
Journal of cardiovascular pharmacology 1998;31(3):408-17.
1998: Daniel Hayoz; Jan G Hengstler; B Noel; Hans R Brunner
Vasopressin induces opposite changes in blood flow in the skin and the muscular circulation.
Advances in experimental medicine and biology 1998;449():447-9.
1997: Hans R Brunner
The new angiotensin II receptor antagonist, irbesartan: pharmacokinetic and pharmacodynamic considerations.
American journal of hypertension 1997;10(12 Pt 2):311S-317S.
1997: Anne Zanchi; Hans R Brunner; Daniel Hayoz
Age-related changes of the mechanical properties of the carotid artery in spontaneously hypertensive rats.
Journal of hypertension 1997;15(12 Pt 1):1415-22.
1997: R Weber; A Pechère-Bertschi; Daniel Hayoz; V Gerc; R Brouard; J P Lahmy; Hans R Brunner; Michel Burnier
Effects of SR 49059, a new orally active and specific vasopressin V1 receptor antagonist, on vasopressin-induced vasoconstriction in humans.
Hypertension 1997;30(5):1121-7.
1997: Bernard Waeber; Hans R Brunner
[Measurement of blood pressure: best way to assess cardiovascular risk?].
Archives des maladies du coeur et des vaisseaux 1997;90 Spec No 5():11-3.
1997: Bernard Waeber; Hans R Brunner
Combination antihypertensive therapy: does it have a role in rational therapy?
American journal of hypertension 1997;10(7 Pt 2):131S-137S.
1997: Anne Zanchi; P Wiesel; Jean-François Aubert; Hans R Brunner; Daniel Hayoz
Time course changes of the mechanical properties of the carotid artery in renal hypertensive rats.
Hypertension 1997;29(5):1199-203.
1997: M Hagmann; Jürg Nussberger; R B Naudin; T S Burns; A Karim; Bernard Waeber; Hans R Brunner
SC-52458, an orally active angiotensin II-receptor antagonist: inhibition of blood pressure response to angiotensin II challenges and pharmacokinetics in normal volunteers.
Journal of cardiovascular pharmacology 1997;29(4):444-50.
1997: B Waeber; Hans R Brunner
Low-dose combinations versus monotherapies in the treatment of hypertension.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1997;15(2):S17-20.
1997: Daniel Hayoz; R Weber; A Pechère; M Burnier; Hans R Brunner
Heterogeneous vascular response to vasopressin: radial artery versus forearm blood flow.
Journal of hypertension 1997;15(1):35-41.
1997: Chantal Csajka; Thierry Buclin; Hans R Brunner; Jérôme Biollaz
Pharmacokinetic-pharmacodynamic profile of angiotensin II receptor antagonists.
Clinical pharmacokinetics 1997;32(1):1-29.
1996: Bernard Waeber; Michel Burnier; Jürg Nussberger; Hans R Brunner
Experience with angiotensin II antagonists in hypertensive patients.
Clinical and experimental pharmacology & physiology 1996;23 Suppl 3():S142-6.
1996: B Noël; G Del Re; P Capone; Hans R Brunner; Jürg Nussberger
Clinical and hormonal effects of the new angiotensin II receptor antagonist LRB081.
Journal of cardiovascular pharmacology 1996;28(2):252-8.
1996: Bernard Waeber; Hans R Brunner
Angiotensin II antagonists: a new class of antihypertensive agent.
The British journal of clinical practice 1996;50(5):265-8.
1996: M Burnier; F Roch-Ramel; Hans R Brunner
Renal effects of angiotensin II receptor blockade in normotensive subjects.
Kidney international 1996;49(6):1787-90.
1996: R Weber; Nikos Stergiopulos; Hans R Brunner; Daniel Hayoz
Contributions of vascular tone and structure to elastic properties of a medium-sized artery.
Hypertension 1996;27(3 Pt 2):816-22.
1996: Bernard Waeber; A Pechere; M Burnier; Hans R Brunner
[Diagnosis and treatment of arterial hypertension in the elderly].
Praxis 1996;85(6):150-4.
1996: Hans R Brunner; Bernard Waeber
Do we need new antihypertensive drugs?
Journal of cardiovascular pharmacology 1996;27 Suppl 3():S1-4.
1996: D Evéquoz; Jean-François Aubert; Jürg Nussberger; Jérôme Biollaz; J Diezi; Hans R Brunner; Bernard Waeber
Effects of neuropeptide Y on intrarenal hemodynamics, plasma renin activity and urinary sodium excretion in rats.
Nephron 1996;73(3):467-72.
1996: Bernard Waeber; Hans R Brunner
Cardiovascular hypertrophy: role of angiotensin II and bradykinin.
Journal of cardiovascular pharmacology 1996;27 Suppl 2():S36-40.
1995: Anne Zanchi; E Delacrétaz; V Taleb; R Gaillard; B Jeanrenaud; Hans R Brunner; Bernard Waeber
Endothelial function of the mesenteric arteriole and mechanical behaviour of the carotid artery in rats with insulin resistance and hypercholesterolaemia.
Journal of hypertension 1995;13(12 Pt 1):1463-70.
1995: C A Porret; Nikos Stergiopulos; Daniel Hayoz; Hans R Brunner; Jean-Jacques Meister
Simultaneous ipsilateral and contralateral measurements of vasomotion in conduit arteries of human upper limbs.
The American journal of physiology 1995;269(6 Pt 2):H1852-8.
1995: Daniel Hayoz; R Weber; B Rutschmann; R Darioli; Michel Burnier; Bernard Waeber; Hans R Brunner
Postischemic blood flow response in hypercholesterolemic patients.
Hypertension 1995;26(3):497-502.
1995: D Evéquoz; Eric Grouzmann; Jürg Nussberger; M Niederberger; Hans R Brunner; Bernard Waeber
Beta-adrenoceptor stimulation increases neuropeptide Y release from sympathetic nerves in intact rats.
Regulatory peptides 1995;58(3):163-6.
1995: Bernard Waeber; Hans R Brunner
Main objectives and new aspects of combination treatment of hypertension.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1995;13(2):S15-9.
1995: E Delacrétaz; Anne Zanchi; Jürg Nussberger; Daniel Hayoz; Jean-François Aubert; Hans R Brunner; Bernard Waeber
Chronic nitric oxide synthase inhibition and carotid artery distensibility in renal hypertensive rats.
Hypertension 1995;26(2):332-6.
1995: M Burnier; A Pechère-Bertschi; Jürg Nussberger; Bernard Waeber; Hans R Brunner
Studies of the renal effects of angiotensin II receptor blockade: the confounding factor of acute water loading on the action of vasoactive systems.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1995;26(1):108-15.
1995: B Favrat; M Burnier; Jürg Nussberger; J M Lecomte; R Brouard; Bernard Waeber; Hans R Brunner
Neutral endopeptidase versus angiotensin converting enzyme inhibition in essential hypertension.
Journal of hypertension 1995;13(7):797-804.
1995: Anne Zanchi; Jean-François Aubert; Hans R Brunner; Bernard Waeber
Vascular acetylcholine response during chronic NO synthase inhibition: in vivo versus in vitro.
Cardiovascular research 1995;30(1):122-9.
1995: H Achakri; Nikos Stergiopulos; N Hoogerwerf; Daniel Hayoz; Hans R Brunner; Jean-Jacques Meister
Intraluminal pressure modulates the magnitude and the frequency of induced vasomotion in rat arteries.
Journal of vascular research 1995;32(4):237-46.
1995: Thierry Pedrazzini; Pascal Cousin; Jean-François Aubert; Hans R Brunner
Transient inhibition of angiotensinogen production in transgenic mice bearing an antisense angiotensinogen gene.
Kidney international 1995;47(6):1638-46.
1995: N Inglessis; Jürg Nussberger; M Hagmann; O Hiesse-Provost; J Insuasty; J Reid; J Ménard; Hans R Brunner
Comparison of the angiotensin II antagonist UP269-6 with the angiotensin converting enzyme inhibitor enalapril in normotensive volunteers challenged with angiotensin I.
Journal of cardiovascular pharmacology 1995;25(6):986-93.
1995: E Delacrétaz; N de Quay; Bernard Waeber; Yvan Vial; P E Schulz; Michel Burnier; Hans R Brunner; H Bossart; N C Schaad
Differential nitric oxide synthase activity in human platelets during normal pregnancy and pre-eclampsia.
Clinical science (London, England : 1979) 1995;88(6):607-10.
1995: Anne Zanchi; N C Schaad; M C Osterheld; E Grouzmann; Jürg Nussberger; Hans R Brunner; Bernard Waeber
Effects of chronic NO synthase inhibition in rats on renin-angiotensin system and sympathetic nervous system.
The American journal of physiology 1995;268(6 Pt 2):H2267-73.
1995: M Burnier; M Hagman; Jürg Nussberger; J Biollaz; C Armagnac; R Brouard; B Weber; Hans R Brunner
Short-term and sustained renal effects of angiotensin II receptor blockade in healthy subjects.
Hypertension 1995;25(4 Pt 1):602-9.
1995: M Niederberger; Jean-François Aubert; Jürg Nussberger; Hans R Brunner; Bernard Waeber
Sympathetic nerve activity in conscious renal hypertensive rats treated with an angiotensin converting enzyme inhibitor or an angiotensin II antagonist.
Journal of hypertension 1995;13(4):439-45.
1995: Daniel Hayoz; R Weber; E Delacrétaz; Hans R Brunner
[Noninvasive assessment of morphology and function of the great vessels].
Schweizerische medizinische Wochenschrift 1995;125(7):283-7.
1995: E Delacrétaz; Jürg Nussberger; J Biollaz; Bernard Waeber; Hans R Brunner
Characterization of the angiotensin II receptor antagonist TCV-116 in healthy volunteers.
Hypertension 1995;25(1):14-21.
1995: D Hayoz; R Weber; Hans R Brunner
Prevention of vascular remodelling in cardiovascular disease.
Cardiology 1995;86 Suppl 1():23-9.
1994: Hans R Brunner; Jürg Nussberger; Bernard Waeber
Dose-response relationships of ACE inhibitors and angiotensin II blockers.
European heart journal 1994;15 Suppl D():123-8.
1994: Jürg Nussberger; E Fleck; H Bahrmann; W Delius; Heinz-Peter Schultheiss; Hans R Brunner
Dose-related effects of ACE inhibition in man: quinapril in patients with moderate congestive heart failure. The Study Group on Neurohormonal Regulation in Congestive Heart Failure: Lausanne, Switzerland; Berlin, Düsseldorf, Munich, Germany.
European heart journal 1994;15 Suppl D():113-22.
1994: Hans R Brunner; E Delacrétaz; Jürg Nussberger; Michel Burnier; Bernard Waeber
Angiotensin II antagonists DuP 753 and TCV 116.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1994;12(9):S29-34.
1994: A Pellacani; Hans R Brunner; Jürg Nussberger
Plasma kinins increase after angiotensin-converting enzyme inhibition in human subjects.
Clinical science (London, England : 1979) 1994;87(5):567-74.
1994: D Evéquoz; Eric Grouzmann; Annette G Beck-Sickinger; Hans R Brunner; Bernard Waeber
Differential vascular effects of neuropeptide Y(NPY) selective receptor agonists.
Experientia 1994;50(10):936-8.
1994: M Burnier; Hans R Brunner
Angiotensin II receptor antagonists and the kidney.
Current opinion in nephrology and hypertension 1994;3(5):537-45.
1994: E Delacrétaz; Jürg Nussberger; K Püchler; A J Wood; P R Robinson; Bernard Waeber; Hans R Brunner
Value of different clinical and biochemical correlates to assess angiotensin converting enzyme inhibition.
Journal of cardiovascular pharmacology 1994;24(3):479-85.
1994: Thomas Münzel; Daniel Hayoz; B Hornig; S Kurz; H Just; B Zelis; Hans R Brunner; Helmut Drexler
[Increased vascular sensitivity to nitroglycerin in patients with hypercholesterolemia and peripheral endothelial dysfunction].
Deutsche medizinische Wochenschrift (1946) 1994;119(31-32):1065-70.
1994: Bernard Waeber; M Burnier; G Heynen; Hans R Brunner
Clinical utility of ambulatory blood pressure monitoring in the evaluation of patients with borderline hypertension.
Journal of cardiovascular risk 1994;1(2):120-6.
1994: Anne Zanchi; Jürg Nussberger; M Criscuoli; P Capone; Hans R Brunner
Angiotensin-converting enzyme inhibition by hydroxamic zinc-binding idrapril in humans.
Journal of cardiovascular pharmacology 1994;24(2):317-22.
1994: M Burnier; Bernard Waeber; Hans R Brunner
The advantages of angiotensin II antagonism.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1994;12(2):S7-15.
1994: E Delacrétaz; Daniel Hayoz; M C Osterheld; C Y Genton; Hans R Brunner; Bernard Waeber
Long-term nitric oxide synthase inhibition and distensibility of carotid artery in intact rats.
Hypertension 1994;23(6 Pt 2):967-70.
1994: M Burnier; G Centeno; E Burki; Hans R Brunner
Confocal microscopy to analyze cytosolic and nuclear calcium in cultured vascular cells.
The American journal of physiology 1994;266(4 Pt 1):C1118-27.
1994: Helmut Drexler; Daniel Hayoz; Thomas Münzel; H Just; R Zelis; Hans R Brunner
Endothelial dysfunction in chronic heart failure. Experimental and clinical studies.
Arzneimittel-Forschung 1994;44(3A):455-8.
1994: D Evequoz; Michel Burnier; M Niederberger; Hans R Brunner; Jürg Nussberger; Bernard Waeber
Mechanisms of the pressor response to intravenous thyrotropin-releasing hormone in the rat.
Clinical and experimental pharmacology & physiology 1994;21(2):93-100.
1994: E Grouzmann; G Alvarez-Bolado; C Meyer; M C Osterheld; Michel Burnier; Hans R Brunner; Bernard Waeber
Localization of neuropeptide Y and its C-terminal flanking peptide in human renal tissue.
Peptides 1994;15(8):1377-82.
1993: Bernard Waeber; Hans R Brunner
Ambulatory blood pressure monitoring to assess antihypertensive therapy in private practice.
Journal of human hypertension 1993;7(6):563-6.
1993: Bernard Waeber; G Heynen; Hans R Brunner
[The importance of therapy compliance in the treatment of arterial hypertension].
Schweizerische Rundschau für Medizin Praxis = Revue suisse de médecine Praxis 1993;82(48):1387-9.
1993: Hans R Brunner; Jürg Nussberger; Bernard Waeber
Control of vascular tone by renin and angiotensin in cardiovascular disease.
European heart journal 1993;14 Suppl I():149-53.
1993: Hans R Brunner; Jürg Nussberger; Michel Burnier; Bernard Waeber
Angiotensin II antagonists.
Clinical and experimental hypertension (New York, N.Y. : 1993) 1993;15(6):1221-38.
1993: Michel Burnier; B Rutschmann; Jürg Nussberger; J Versaggi; S Shahinfar; Bernard Waeber; Hans R Brunner
Salt-dependent renal effects of an angiotensin II antagonist in healthy subjects.
Hypertension 1993;22(3):339-47.
1993: Daniel Hayoz; B Rutschmann; C Y Genton; M Niederberger; Hans R Brunner; Bernard Waeber
Elastic behaviour of the carotid artery in intact spontaneously hypertensive rats.
European heart journal 1993;14 Suppl C():10-3.
1993: Daniel Hayoz; Yanik Tardy; B Rutschmann; J P Mignot; H Achakri; François Feihl; Jean-Jacques Meister; Bernard Waeber; Hans R Brunner
Spontaneous diameter oscillations of the radial artery in humans.
The American journal of physiology 1993;264(6 Pt 2):H2080-4.
1993: Bernard Waeber; D Wohler; T F Lüscher; J L Schubiger; Hans R Brunner
Antihypertensive efficacy of cilazapril in general practice: assessment by ambulatory blood pressure monitoring.
The American journal of medicine 1993;94(4A):60S-64S.
1993: M Porchet; Jürg Nussberger; Hans R Brunner; Bernard Waeber
[Blood pressure recording in outpatient service: experience with the Sandoz Pressure System].
Schweizerische Rundschau für Medizin Praxis = Revue suisse de médecine Praxis 1993;82(11):320-2.
1993: Hans R Brunner; J Nussberger; B Waeber
Inhibitors of the renin-angiotensin system.
Arzneimittel-Forschung 1993;43(2A):274-8.
1993: P Walker; M Munoz; M C Combe; Eric Grouzmann; Herbert Herzog; L Selbie; J Shine; Hans R Brunner; Bernard Waeber; Riccardo Wittek
High level expression of human neuropeptide Y receptors in mammalian cells infected with a recombinant vaccinia virus.
Molecular and cellular endocrinology 1993;91(1-2):107-12.
1993: Hans R Brunner; Jürg Nussberger; Bernard Waeber
Angiotensin antagonists.
Advances in nephrology from the Necker Hospital 1993;22():305-27.
1993: Thierry Pedrazzini; Hans R Brunner; Bernard Waeber
Neuropeptide Y and cardiovascular regulation.
Current opinion in nephrology and hypertension 1993;2(1):106-13.
1993: D Hayoz; Jürg Nussberger; Bernard Waeber; Hans R Brunner
The renin-angiotensin system and arterial wall behavior.
Journal of cardiovascular pharmacology 1993;22 Suppl 5():S48-52.
1992: Bernard Waeber; P Soret; P N Poget; Hans R Brunner
[Evaluation of the antihypertensive efficacy of isradipine SRO as assessed by ambulatory blood pressure determination].
Schweizerische Rundschau für Medizin Praxis = Revue suisse de médecine Praxis 1992;81(50):1514-7.
1992: Hans R Brunner; Bernard Waeber; Jürg Nussberger
Strategies for the management of hypertension in aircrew.
European heart journal 1992;13 Suppl H():45-9.
1992: M Burnier; Hans R Brunner
Neurohormonal consequences of diuretics in different cardiovascular syndromes.
European heart journal 1992;13 Suppl G():28-33.
1992: Hans R Brunner; Y Christen; Alain Munafo; R J Lee; Bernard Waeber; Jürg Nussberger
Clinical experience with angiotensin II receptor antagonists.
American journal of hypertension 1992;5(12 Pt 2):243S-246S.
1992: E Grouzmann; Jean-François Aubert; Bernard Waeber; Hans R Brunner
A sensitive and specific two-site, sandwich-amplified enzyme immunoassay for neuropeptide Y.
Peptides 1992;13(6):1049-54.
1992: Bernard Waeber; D Hayoz; D Evéquoz; Hans R Brunner
Arterial compliance and distensibility in spontaneously hypertensive rats.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1992;10(6):S79-81.
1992: R Zelis; Daniel Hayoz; Helmut Drexler; Thomas Münzel; B Hornig; A M Zeiher; H Just; Hans R Brunner
Arterial dilatory reserve in congestive heart failure.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1992;10(6):S65-7.
1992: Daniel Hayoz; Yanik Tardy; B Rutschmann; Bernard Waeber; Jean-Jacques Meister; Hans R Brunner
Effect of mental stress on the tone of a medium-sized muscular artery.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1992;10(6):S57-9.
1992: Jean-Jacques Meister; Yanik Tardy; Nikos Stergiopulos; Daniel Hayoz; Hans R Brunner; J D Etienne
Non-invasive method for the assessment of non-linear elastic properties and stress of forearm arteries in vivo.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1992;10(6):S23-6.
1992: Yanik Tardy; Daniel Hayoz; J P Mignot; P Richard; Hans R Brunner; Jean-Jacques Meister
Dynamic non-invasive measurements of arterial diameter and wall thickness.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1992;10(6):S105-9.
1992: Hans R Brunner
ACE inhibitors in renal disease.
Kidney international 1992;42(2):463-79.
1992: Daniel Hayoz; B Rutschmann; F Perret; M Niederberger; Yanik Tardy; V Mooser; Jürg Nussberger; Bernard Waeber; Hans R Brunner
Conduit artery compliance and distensibility are not necessarily reduced in hypertension.
Hypertension 1992;20(1):1-6.
1992: Daniel Hayoz; Yanik Tardy; F Perret; Bernard Waeber; Jean-Jacques Meister; Hans R Brunner
Non-invasive determination of arterial diameter and distensibility by echo-tracking techniques in hypertension.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1992;10(5):S95-100.
1992: Helmut Drexler; Daniel Hayoz; Thomas Münzel; B Hornig; H Just; Hans R Brunner; R Zelis
Endothelial function in chronic congestive heart failure.
The American journal of cardiology 1992;69(19):1596-601.
1992: Jürg Nussberger; D Brunner; I Keller; Hans R Brunner
Measurement of converting enzyme activity by antibody-trapping of generated angiotensin II. Comparison with two other methods.
American journal of hypertension 1992;5(6 Pt 1):393-8.
1992: Alain Munafo; Y Christen; Jürg Nussberger; L Y Shum; R M Borland; R J Lee; Bernard Waeber; J Biollaz; Hans R Brunner
Drug concentration response relationships in normal volunteers after oral administration of losartan, an angiotensin II receptor antagonist.
Clinical pharmacology and therapeutics 1992;51(5):513-21.
1992: M Ganslmayer; F Perret; Bernard Waeber; Jürg Nussberger; Hans R Brunner
[Preliminary evaluation of the Profilomat, a new portable blood pressure recorder].
Schweizerische medizinische Wochenschrift 1992;122(15):544-8.
1992: Jean-François Aubert; P Walker; E Grouzmann; Jürg Nussberger; Hans R Brunner; Bernard Waeber
Inhibitory effect of neuropeptide Y on stimulated renin secretion of awake rats.
Clinical and experimental pharmacology & physiology 1992;19(4):223-8.
1992: O Raccaud; Bernard Waeber; A Petrillo; Paul H Wiesel; J R Hofstetter; Hans R Brunner
Ambulatory blood pressure monitoring as a means to avoid overtreatment of elderly hypertensive patients.
Gerontology 1992;38(1-2):99-104.
1992: A Pellacani; Hans R Brunner; Jürg Nussberger
Antagonizing and measurement: approaches to understanding of hemodynamic effects of kinins.
Journal of cardiovascular pharmacology 1992;20 Suppl 9():S28-34.
1991: M Niederberger; Daniel Hayoz; B Rutschmann; Yanik Tardy; Jürg Nussberger; Bernard Waeber; Hans R Brunner
Neither hydralazine nor captopril significantly shifts carotid artery distensibility-pressure curves determined in intact spontaneously hypertensive rats.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1991;9(6):S404-5.
1991: Jürg Nussberger; J P Flückiger; K Y Hui; D Evéquoz; Bernard Waeber; Hans R Brunner
Angiotensin I and II disappear completely from circulating blood within 48 hours after binephrectomy: improved measurement of angiotensins in rat plasma.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1991;9(6):S230-1.
1991: Bernard Waeber; B Rutschmann; J Nüssberger; Hans R Brunner
Evaluation of antihypertensive therapy: discrepancies between office and ambulatory recorded blood pressure.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1991;9(3):S53-6.
1991: Bernard Waeber; M Niederberger; Jürg Nussberger; Hans R Brunner
Ambulatory blood pressure monitoring in children, adolescents and elderly people.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1991;9(8):S72-4.
1991: Daniel Hayoz; B Rutschmann; M Niederberger; Bernard Waeber; Hans R Brunner
[Non invasive measurement of arterial compliance].
Archives des maladies du coeur et des vaisseaux 1991;84 Spec No 3():73-6.
1991: E Camenzind; Jürg Nussberger; L Juillerat; Alain Munafo; W Fischli; Philippe Coassolo; P van Brummelen; C H Kleinbloesem; Bernard Waeber; Hans R Brunner
Effect of the renin response during renin inhibition: oral Ro 42-5892 in normal humans.
Journal of cardiovascular pharmacology 1991;18(3):299-307.
1991: Michel Burnier; M Ganslmayer; F Perret; M Porchet; T Kosoglou; A Gould; Jürg Nussberger; Bernard Waeber; Hans R Brunner
Effects of SCH 34826, an orally active inhibitor of atrial natriuretic peptide degradation, in healthy volunteers.
Clinical pharmacology and therapeutics 1991;50(2):181-91.
1991: D Evéquoz; T Reichenstein; Bernard Waeber; Jürg Nussberger; Hans R Brunner
[ACE inhibitors in the treatment of hypertension in elderly patients].
Schweizerische Rundschau für Medizin Praxis = Revue suisse de médecine Praxis 1991;80(25):701-6.
1991: Michel Burnier; G Centeno; E Grouzmann; P Walker; Bernard Waeber; Hans R Brunner
In vitro effects of DuP 753, a nonpeptide angiotensin II receptor antagonist, on human platelets and rat vascular smooth muscle cells.
American journal of hypertension 1991;4(5 Pt 1):438-43.
1991: Y Christen; Bernard Waeber; Jürg Nussberger; M Porchet; R M Borland; R J Lee; K Maggon; L Shum; P B Timmermans; Hans R Brunner
Oral administration of DuP 753, a specific angiotensin II receptor antagonist, to normal male volunteers. Inhibition of pressor response to exogenous angiotensin I and II.
Circulation 1991;83(4):1333-42.
1991: Y Christen; Bernard Waeber; Jürg Nussberger; R J Lee; P B Timmermans; Hans R Brunner
Dose-response relationships following oral administration of DuP 753 to normal humans.
American journal of hypertension 1991;4(4 Pt 2):350S-353S.
1991: Yanik Tardy; Jean-Jacques Meister; F Perret; Hans R Brunner; Marcel Arditi
Non-invasive estimate of the mechanical properties of peripheral arteries from ultrasonic and photoplethysmographic measurements.
Clinical physics and physiological measurement : an official journal of the Hospital Physicists' Association, Deutsche Gesellschaft für Medizinische Physik and the European Federation of Organisations for Medical Physics 1991;12(1):39-54.
1991: Urs Scherrer; Jürg Nussberger; S Torriani; Bernard Waeber; R Darioli; J R Hofstetter; Hans R Brunner
Effect of weight reduction in moderately overweight patients on recorded ambulatory blood pressure and free cytosolic platelet calcium.
Circulation 1991;83(2):552-8.
1990: S Vonmoos; Jürg Nussberger; Bernard Waeber; Jérôme Biollaz; Hans R Brunner; P Leuenberger
Effect of metoclopramide on angiotensins, aldosterone, and atrial peptide during hypoxia.
Journal of applied physiology (Bethesda, Md. : 1985) 1990;69(6):2072-7.
1990: Hans R Brunner; Jürg Nussberger; Bernard Waeber
Various approaches to blockade of the renin-angiotensin system: persistent renin response.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1990;8(7):S149-53.
1990: Y Christen; M Ganslmayer; Bernard Waeber; M Burnier; Jürg Nussberger; Hans R Brunner
Use of non-invasive ambulatory blood pressure monitoring to screen for high-risk hypertensive patients.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1990;8(6):S119-24.
1990: L Juillerat; Jürg Nussberger; J Ménard; V Mooser; Y Christen; Bernard Waeber; P Graf; Hans R Brunner
Determinants of angiotensin II generation during converting enzyme inhibition.
Hypertension 1990;16(5):564-72.
1990: Bernard Waeber; Michel Burnier; Jürg Nussberger; Hans R Brunner
Trials using a crossover design and ambulatory blood pressure recordings to determine the efficacy of antihypertensive agents in individual patients.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1990;8(4):S37-41.
1990: Y Christen; Bernard Waeber; Jürg Nussberger; Hans R Brunner
Noninvasive blood pressure monitoring at the finger for studying short lasting pressor responses in man.
Journal of clinical pharmacology 1990;30(8):711-4.
1990: Jürg Nussberger; V Mooser; G Maridor; L Juillerat; Bernard Waeber; Hans R Brunner
Caffeine-induced diuresis and atrial natriuretic peptides.
Journal of cardiovascular pharmacology 1990;15(5):685-91.
1990: V Mooser; Jürg Nussberger; L Juillerat; Michel Burnier; Bernard Waeber; J Bidiville; N Pauly; Hans R Brunner
Reactive hyperreninemia is a major determinant of plasma angiotensin II during ACE inhibition.
Journal of cardiovascular pharmacology 1990;15(2):276-82.
1990: Bernard Waeber; Jürg Nussberger; Hans R Brunner
[Angiotensin-converting-enzyme inhibition in arterial hypertension].
Wiener medizinische Wochenschrift (1946) 1990;140(1-2):22-30.
1990: Anne-Laure Lattion; J P Flückiger; Bernard Waeber; Jürg Nussberger; Jean-François Aubert; Hans R Brunner
Influence of sodium balance on atrial natriuretic factor in rats with one-kidney, one-clip renal hypertension.
Experientia 1990;46(1):69-72.
1990: Bernard Waeber; D Evéquoz; Jean-François Aubert; J P Flückiger; L Juillerat; Jürg Nussberger; Hans R Brunner
Prevention of renal hypertension in the rat by neuropeptide Y.
Journal of hypertension 1990;8(1):21-5.
1990: Bernard Waeber; Jürg Nussberger; Eric Grouzmann; Michel Burnier; Hans R Brunner
Determination of plasma catecholamine and vasoactive peptide concentrations: clinical usefulness.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1990;17(7):667-72.
1990: J P Flückiger; R Deghenghi; Bernard Waeber; H U Immer; Jürg Nussberger; Hans R Brunner
Effects of dextronatrin on blood pressure, hematocrit, urinary sodium excretion and sympathetic nerve activity of rats.
Fundamental & clinical pharmacology 1990;4(2):129-39.
1990: Bernard Waeber; M Niederberger; H Gavras; Jürg Nussberger; Hans R Brunner
Hemodynamic effects of a kinin antagonist.
Journal of cardiovascular pharmacology 1990;15 Suppl 6():S78-82.
1989: Hans R Brunner; Bernard Waeber; J Nussberger
Angiotensin-converting enzyme inhibition versus blockade of the renin-angiotensin system.
The American journal of medicine 1989;87(6B):15S-18S.
1989: Michel Burnier; Bernard Waeber; Jürg Nussberger; Hans R Brunner
Effect of angiotensin converting enzyme inhibition in renovascular hypertension.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1989;7(7):S27-31.
1989: F Perret; V Mooser; Bernard Waeber; T Yanik; M Jean-Jacques; E Mooser; Jürg Nussberger; Hans R Brunner
Effect of cold pressor test on the internal diameter of the radial artery.
American journal of hypertension 1989;2(9):727-8.
1989: J P Flückiger; G Gremaud; Bernard Waeber; A Kulik; A Ichino; Jürg Nussberger; Hans R Brunner
Measurement of sympathetic nerve activity in the unanesthetized rat.
Journal of applied physiology (Bethesda, Md. : 1985) 1989;67(1):250-5.
1989: Jürg Nussberger; A Delabays; M De Gasparo; F Cumin; Bernard Waeber; Hans R Brunner; J Ménard
Hemodynamic and biochemical consequences of renin inhibition by infusion of CGP 38560A in normal volunteers.
Hypertension 1989;13(6 Pt 2):948-53.
1989: A Delabays; Jürg Nussberger; M Porchet; Bernard Waeber; P Hoyos; R Boger; H Glassman; H D Kleinert; R Luther; Hans R Brunner
Hemodynamic and humoral effects of the new renin inhibitor enalkiren in normal humans.
Hypertension 1989;13(6 Pt 2):941-7.
1989: Bernard Waeber; Michel Burnier; F Perret; Jürg Nussberger; Hans R Brunner
Ambulatory blood pressure measurement and antihypertensive therapy.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1989;7(3):S33-9.
1989: Bernard Waeber; Jürg Nussberger; L Perret; J P Santoni; Hans R Brunner
Experience with perindopril in normal volunteers.
Archives des maladies du coeur et des vaisseaux 1989;82 Spec No 1():35-41.
1989: Michel Burnier; V Mooser; J P Wauters; H K Marder; P De Vane; Jürg Nussberger; Bernard Waeber; Hans R Brunner
Bolus injections of synthetic atrial natriuretic peptide in patients with chronic renal failure or nephrotic syndrome.
Journal of cardiovascular pharmacology 1989;13(5):682-90.
1989: Jürg Nussberger; Bernard Waeber; Hans R Brunner
Angiotensin converting enzyme inhibition and renin inhibition.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1989;7(2):S75-9.
1989: Jürg Nussberger; Bernard Waeber; Hans R Brunner
Plasma angiotensin II and the antihypertensive action of angiotensin-converting enzyme inhibition.
American journal of hypertension 1989;2(4):286-93.
1989: V Mooser; Michel Burnier; Jürg Nussberger; L Juillerat; Bernard Waeber; Hans R Brunner
Effects of smoking and physical exercise on platelet free cytosolic calcium in healthy normotensive volunteers.
Journal of hypertension 1989;7(3):211-6.
1989: Michel Burnier; Bernard Waeber; Jürg Nussberger; Hans R Brunner
Pharmacokinetics of angiotensin converting enzyme inhibitors.
British journal of clinical pharmacology 1989;28 Suppl 2():133S-139S; discussion 140S.
1989: Jürg Nussberger; Bernard Waeber; Hans R Brunner
Clinical pharmacology of ACE inhibition.
Cardiology 1989;76 Suppl 2():11-22.
1989: Bernard Waeber; L Juillerat-Jeanneret; Jean-François Aubert; M Schapira; Jürg Nussberger; Hans R Brunner
Involvement of the kallikrein-kinin system in the antihypertensive effect of the angiotensin converting enzyme inhibitors.
British journal of clinical pharmacology 1989;27 Suppl 2():175S-180S.
1989: Bernard Waeber; Jürg Nussberger; L Perret; J P Santoni; Hans R Brunner
Experience with perindopril in normal volunteers.
Clinical and experimental hypertension. Part A, Theory and practice 1989;11 Suppl 2():507-19.
1989: P Y Erard; J P Gardaz; Jürg Nussberger; J J Livio; Bernard Waeber; Hans R Brunner; J Freeman
[Effects of clonidine on tourniquet-induced systemic arterial hypertension in general anesthesia].
Annales françaises d'anesthèsie et de rèanimation 1989;8 Suppl():R198.
1989: Gérard Waeber; M Burnier; M Porchet; Jürg Nussberger; Bernard Waeber; Hans R Brunner
Effects of prolonged administration of the angiotensin converting enzyme inhibitor CGS 16617 in normotensive volunteers.
European journal of clinical pharmacology 1989;36(6):587-91.
1989: Michel Burnier; V Mooser; Jürg Nussberger; Bernard Waeber; Hans R Brunner
Correlation between plasma concentration of cilazapril and haemodynamic and hormonal effects in healthy man.
British journal of clinical pharmacology 1989;27 Suppl 2():189S-197S.
1989: Bernard Waeber; Jürg Nussberger; L Juillerat; Hans R Brunner
Angiotensin converting enzyme inhibition: discrepancy between antihypertensive effect and suppression of enzyme activity.
Journal of cardiovascular pharmacology 1989;14 Suppl 4():S53-9.
1989: A Delabays; M Porchet; Bernard Waeber; Jürg Nussberger; Hans R Brunner
Effects of intranasal administration of synthetic (4-28)human atrial natriuretic peptide to normal volunteers.
Journal of cardiovascular pharmacology 1989;13(1):173-6.
1988: Jürg Nussberger; I Keller; Bernard Waeber; Hans R Brunner
Angiotensin II measurement with high-affinity monoclonal antibodies.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1988;6(4):S424-5.
1988: V Mooser; Bernard Waeber; Jürg Nussberger; Hans R Brunner
Antihypertensive effect of diltiazem administered once and twice daily.
Journal of human hypertension 1988;2(4):257-60.
1988: Hans R Brunner; Bernard Waeber; Jürg Nussberger
What we would like to know about the antihypertensive mechanisms of angiotensin converting enzyme inhibition.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1988;6(3):S1-5.
1988: Albert Mimran; Jürg Nussberger; Jean Ribstein; Bernard Waeber; Hans R Brunner
Response of atrial natriuretic peptide to acute saline loading in essential hypertension.
The American journal of physiology 1988;255(6 Pt 2):F1085-90.
1988: Gérard Waeber; Marc Schapira; Bernard Waeber; Jean-François Aubert; Jürg Nussberger; Hans R Brunner
Hypotensive effect of the active fragment derived from factor XII is mediated by an activation of the plasma kallikrein-kinin system.
Circulatory shock 1988;26(4):375-82.
1988: S Torriani; Bernard Waeber; A Petrillo; R Di Stefano; V Mooser; Urs Scherrer; Jürg Nussberger; J R Hofstetter; Hans R Brunner
Ambulatory blood pressure monitoring in the elderly hypertensive patient.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1988;6(1):S25-7.
1988: Bernard Waeber; Jean-François Aubert; J P Flückiger; Jürg Nussberger; R J Vavrek; J M Stewart; Hans R Brunner
Role of endogenous bradykinin in blood pressure control of conscious rats.
Kidney international. Supplement 1988;26():S63-8.
1988: Hans R Brunner; Bernard Waeber; Jürg Nussberger
Renin secretion responsiveness: understanding the efficacy of renin-angiotensin inhibition.
Kidney international. Supplement 1988;26():S80-5.
1988: Jean-François Aubert; Bernard Waeber; Bernard C Rossier; Käthi Geering; Jürg Nussberger; Hans R Brunner
Effects of neuropeptide Y on the blood pressure response to various vasoconstrictor agents.
The Journal of pharmacology and experimental therapeutics 1988;246(3):1088-92.
1988: A Petrillo; Urs Scherrer; J J Gonvers; Jürg Nussberger; H Marder; P de Vane; Bernard Waeber; J R Hofstetter; Hans R Brunner
Atrial natriuretic peptide administered as intravenous infusion or bolus injection to patients with liver cirrhosis and ascites.
Journal of cardiovascular pharmacology 1988;12(3):279-85.
1988: Anne-Laure Lattion; Jean-François Aubert; J P Flückiger; Jürg Nussberger; Bernard Waeber; Hans R Brunner
Effect of sodium intake on gene expression and plasma levels of ANF in rats.
The American journal of physiology 1988;255(2 Pt 2):H245-9.
1988: Bernard Waeber; Jean-François Aubert; R Corder; D Evéquoz; Jürg Nussberger; R Gaillard; Hans R Brunner
Cardiovascular effects of neuropeptide Y.
American journal of hypertension 1988;1(2):193-9.
1988: Gérard Waeber; G Beck; Bernard Waeber; J Bidiville; Jürg Nussberger; Hans R Brunner
Comparison of betaxolol with verapamil in hypertensive patients: discrepancy between office and ambulatory blood pressures.
Journal of hypertension 1988;6(3):239-45.
1988: Michel Burnier; Bernard Waeber; Jean-François Aubert; Jürg Nussberger; Hans R Brunner
Effects of nonhypotensive endotoxemia in conscious rats: role of prostaglandins.
The American journal of physiology 1988;254(3 Pt 2):H509-16.
1988: Jean-François Aubert; Michel Burnier; Bernard Waeber; Jürg Nussberger; D J Dipette; J F Burris; Hans R Brunner
Effects of a nonpressor dose of neuropeptide Y on cardiac output, regional blood flow distribution and plasma renin, vasopressin and catecholamine levels.
The Journal of pharmacology and experimental therapeutics 1988;244(3):1109-15.
1988: J Bidiville; Jürg Nussberger; Gérard Waeber; M Porchet; Bernard Waeber; Hans R Brunner
Individual responses to converting enzyme inhibitors and calcium antagonists.
Hypertension 1988;11(2):166-73.
1988: D Evéquoz; Bernard Waeber; Jean-François Aubert; J P Flückiger; Jürg Nussberger; Hans R Brunner
Neuropeptide Y prevents the blood pressure fall induced by endotoxin in conscious rats with adrenal medullectomy.
Circulation research 1988;62(1):25-30.
1988: J Bidiville; Gérard Waeber; M Porchet; Jürg Nussberger; J Biollaz; H Gomez; L Callahan; Bernard Waeber; Hans R Brunner
Hemodynamic, renal, and endocrine effects of 4-h infusions of human atrial natriuretic peptide in normal volunteers.
Fundamental & clinical pharmacology 1988;2(5):413-29.
1988: Jürg Nussberger; D B Brunner; Bernard Waeber; Hans R Brunner
In vitro renin inhibition to prevent generation of angiotensins during determination of angiotensin I and II.
Life sciences 1988;42(17):1683-8.
1988: E Burgener; V Mooser; Bernard Waeber; M Porchet; J P Gardaz; Jürg Nussberger; Hans R Brunner
Calcium entry blockade attenuates the acute blood pressure rise induced by cigarette smoking.
Journal of cardiovascular pharmacology 1988;12 Suppl 6():S126-30.
1988: Jean-Jacques Goy; Bernard Waeber; Jürg Nussberger; J Bidiville; Jérôme Biollaz; P Nicod; V Mooser; Lukas Kappenberger; Hans R Brunner
Infusion of atrial natriuretic peptide to patients with congestive heart failure.
Journal of cardiovascular pharmacology 1988;12(5):562-70.
1988: J P Flückiger; Bernard Waeber; A Mimran; Jürg Nussberger; W K Wahba; Hans R Brunner
Enhanced urinary kallikrein excretion in response to a moderate sodium load in genetically hypertensive rats.
Journal of cardiovascular pharmacology 1988;12 Suppl 3():S36-42.
1988: Jean-François Aubert; Bernard Waeber; Jürg Nussberger; R Vavrek; J M Stewart; Hans R Brunner
Influence of endogenous bradykinin on acute blood pressure response to vasopressors in normotensive rats assessed with a bradykinin antagonist.
Journal of cardiovascular pharmacology 1988;11(1):51-5.
1987: D Evéquoz; Bernard Waeber; R Corder; Jürg Nussberger; R Gaillard; Hans R Brunner
Markedly reduced blood pressure responsiveness in endotoxemic rats; reversal by neuropeptide Y.
Life sciences 1987;41(23):2573-80.
1987: D Evéquoz; Bernard Waeber; G Matsueda; Jürg Nussberger; Hans R Brunner
Differential blood pressure response to atriopeptin III and sodium nitroprusside in conscious rats with adrenal medullectomy.
European journal of pharmacology 1987;144(2):217-21.
1987: V Mooser; Gérard Waeber; J Bidiville; Bernard Waeber; Jürg Nussberger; Hans R Brunner
Kalemia during combined therapy with an angiotensin converting enzyme inhibitor and a potassium-sparing diuretic.
Journal of clinical hypertension 1987;3(4):510-3.
1987: M D Schaller; Jürg Nussberger; François Feihl; Bernard Waeber; Hans R Brunner; C Perret; P Nicod
Clinical and hemodynamic correlates of elevated plasma arginine vasopressin after acute myocardial infarction.
The American journal of cardiology 1987;60(14):1178-80.
1987: Jean-François Aubert; Michel Burnier; Bernard Waeber; Jürg Nussberger; Hans R Brunner
Nicotine-induced release of vasopressin in the conscious rat: role of opioid peptides and hemodynamic effects.
The Journal of pharmacology and experimental therapeutics 1987;243(2):681-5.
1987: Jérôme Biollaz; J Bidiville; J Diézi; Bernard Waeber; Jürg Nussberger; F Brunner-Ferber; H J Gomez; Hans R Brunner
Site of the action of a synthetic atrial natriuretic peptide evaluated in humans.
Kidney international 1987;32(4):537-46.
1987: Bernard Waeber; Urs Scherrer; A Petrillo; J Bidiville; Jürg Nussberger; Gérard Waeber; J R Hofstetter; Hans R Brunner
Are some hypertensive patients overtreated? A prospective study of ambulatory blood pressure recording.
Lancet 1987;2(8561):732-4.
1987: Bernard Waeber; R Corder; Jean-François Aubert; Jürg Nussberger; R Gaillard; Hans R Brunner
Influence of sodium intake on circulating levels of neuropeptide Y.
Life sciences 1987;41(11):1391-6.
1987: Bernard Waeber; Jean-François Aubert; Jürg Nussberger; R Vavrek; J M Stewart; Hans R Brunner
Influence of bradykinin on blood pressure regulation of spontaneously hypertensive rats maintained on different sodium intakes.
Clinical and experimental pharmacology & physiology 1987;14(8):659-64.
1987: Jean-François Aubert; Bernard Waeber; Jürg Nussberger; R Vavrek; J M Stewart; Hans R Brunner
[Attenuation of the vasopressor effect of angiotensin II, vasopressin and alpha 1-adrenergic stimulation by bradykinin].
Archives des maladies du coeur et des vaisseaux 1987;80(6):832-4.
1987: Jean-François Aubert; Bernard Waeber; Jürg Nussberger; R Vavrek; J M Stewart; Hans R Brunner
Lack of a role of circulating bradykinin in the blood pressure response to acute angiotensin converting enzyme inhibition in rats.
Agents and actions. Supplements 1987;22():349-54.
1987: Hans R Brunner; J Bidiville; Gérard Waeber; M Porchet; Jürg Nussberger; Bernard Waeber
Angiotensin-converting enzyme inhibitor versus calcium antagonist in the treatment of hypertension.
Nephron 1987;47 Suppl 1():87-9.
1987: Jürg Nussberger; M de Gasparo; L Juillerat; T T Guyenne; V Mooser; Bernard Waeber; Hans R Brunner
Rapid measurement of total and active renin: plasma concentrations during acute and sustained converting enzyme inhibition with CGS 14824A.
Clinical and experimental hypertension. Part A, Theory and practice 1987;9(8-9):1353-66.
1987: Hans R Brunner; Jürg Nussberger; J Bidiville; Gérard Waeber; M Porchet; Bernard Waeber
Acute antihypertensive effect of angiotensin converting enzyme inhibition and calcium entry blockade.
Journal of cardiovascular pharmacology 1987;10 Suppl 10():S87-9.
1987: U Kaufmann; Marc Schapira; Bernard Waeber; Jürg Nussberger; Hans R Brunner
Endotoxin-induced hypotension in rats is not mediated by prekallikrein activation.
Circulatory shock 1987;23(3):215-23.